TOKYO, Oct 16 (Reuters): Fujifilm Holdings Corp has announced that it was seeking approval for its flu drug Avigan as a treatment for Covid-19 in Japan, a move that comes after a late-stage study showed reduced recovery time for patients with non-severe symptoms.
Shares of the company closed roughly 3% higher on the news.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
